BHAVANA MANTHA: Open Payments
NPI 1285318907 · DENTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,488 in 84 payments from 28 companies in 2025. Trend: 2023 $83 · 2024 $1,164 · 2025 $1,488
Food & beverage: $1,488
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $234 |
| AstraZeneca Pharmaceuticals LP | 12 | $225 |
| Novo Nordisk Inc | 8 | $140 |
| Amgen Inc. | 6 | $92 |
| GlaxoSmithKline, LLC. | 4 | $87 |
| Lilly USA, LLC | 5 | $78 |
| Corcept Therapeutics | 4 | $73 |
| Astellas Pharma US Inc | 3 | $63 |
| Lundbeck LLC | 3 | $52 |
| PFIZER INC. | 2 | $49 |
Products named: FARXIGA, QULIPTA, Ozempic, MOUNJARO, Korlym, BREZTRI, TRELEGY ELLIPTA, Veozah.
Industry payments across TX — which companies pay providers there.
